Horse Sarcoid: Welfare Management of a Common Tumour

How equine sarcoids affect horses and what welfare-focused treatment decisions look like for the most common tumour in horses.

Key Facts

Sarcoids are the most common tumour in horses, affecting up to 8% of the population in some studies
They are caused by bovine papillomavirus and tend to occur in areas of damaged or thin skin
Sarcoids rarely cause systemic illness but can cause significant local discomfort and welfare problems
Treatment must be tailored to sarcoid type and location — no single approach is universally effective
Inappropriate treatment or repeated trauma can cause aggressive transformation to more problematic forms

Welfare Considerations

Sarcoid management presents welfare challenges because the condition is common, often recurrent, and treatment decisions have welfare implications in both directions. Untreated sarcoids in high-friction areas — girth, bridle contact points, limbs — cause ongoing discomfort and can develop into more aggressive lesions. But inappropriate treatment — particularly surgical excision without adjunct therapy — frequently triggers more aggressive regrowth. Horses with periocular sarcoids face the additional welfare burden of eye involvement. A welfare-first approach to sarcoid management prioritises reducing discomfort, choosing evidence-based treatments, and involving a specialist when lesions are complex.

What You Can Do

Have any skin mass on your horse assessed by a vet rather than leaving it untreated or treating empirically
Consult a specialist if sarcoids are in sensitive locations, multiple, or respond poorly to initial treatment
Use evidence-based treatments — ECT, cisplatin, Liverpool cream, or immunotherapy — rather than home remedies
Protect sarcoid-prone horses from fly irritation, which contributes to lesion development and trauma
Avoid purchasing horses with significant sarcoid burdens without understanding the welfare and management implications